Assessment of Menorrhagia Associated with Intra-Uterine Contraceptive Device (Cut 380a) Among Women Attending Idi-Ogungun Primary Health Care Centre, Ibadan North Local Government Area of Oyo State

Abstract

There is global use of IUD among women. It is seen as the safest and reversible family planning method compared to other methods. It is a wise choice for women within the sexual active period of life that are yet to commence or complete the number of children so desired and to also prevent unwanted pregnancy and the consequences of abortion. For the married couples yet to complete number of children desired it serves as a form of child spacing method of choice with high level reliability. Despite its safety and reversibility, it uses in developing country like America is low, estimated at 2% in 2002 (Mosher, 2004). Based on 2004 United Nations data, Eastern and Western Europe represent 4-5% of global IUD use. The reason for this low practice may be associated with its possible side effects like menorrhagia. However, WHO estimates that approximately 160 million women worldwide use IUDs today. China has an estimated two-thirds of these users, or 96 million. Only a small percentage of current users are in Eastern or Western Europe or other industrialized countries (10%). The remaining 24% are in developing countries other than China, concentrated in Vietnam, Egypt, Indonesia, India, and Uzbekistan, and Turkey – those six countries alone contain half of all users in developing countries excluding China. All developing countries fall into the following clusters, which show widely different determinants of use rates. They also help to identify programmatic reasons for greater or lesser uptake, (WHO, 2007). In Nigeria according to Dinwoke V, Okafor C, Eke A, (2015) in a study conducted in an Eastern Nigerian Teaching Hospital “the IUD was the most popular, being accepted by 56.7% of all clients” of all family methods. This was attributed to some women believe that using modern methods would endanger their health and future fertility. This concede with a study carried out in Port Harcourt, south-south Nigeriaby Enyindah C, Ojule J, Bassey G, indicating IUCD users in the range of 47 to 66% of contraceptive acceptors in different family planning centers and it is used longer than other reversible contraceptive methods. Though it is the safest reversible family planning method studies have associated it with the leading cause of menorrhagia among family planning user as shown in this study compared to other complications in Eastern Nigeria Teaching Hospital in which “No complication 83% 275, Menorrhagia/ irregular bleeding 23%, Abnormal vaginal discharges 4.55% , Missing 0.61%, Othersnonspecific 3.64% and Failure 0% agreeing with the study in South-south Nigeria of Port Harcourt as follows Menorrhagia/ irregular bleeding 30.3%, Amenorrhea 14% , Hypomenorrhea 2.0%, Dysmenorrhea 20.6%, Missing 5.3%, Expulsion 2.7%, Coital discomfort 2.4% ,Coital bleeding 0.6%, Accidental pregnancy 0.3%, Vaginal discharge 20.8%, Lower abdominal pain18.7% and PID 1.5%. However, the investigator is so concern with the association of IUD and menorrhagia. Therefore, the study aim to assess the menorrhagia associated with intra-uterine contraceptive device (Cut 380A) among women attending Idi-Ogungun Primary Health Care Centre, Ibadan North Local Government Area of Oyo State, Nigeria.